Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
暂无分享,去创建一个
F. Pellicanò | E. Bosi | A. Scaramuzza | Emanuele Bosi | F. Cannata | Tino Casetti | V. Miselli | Valerio Miselli | Paolo Di Bartolo | Francesca Pellicano | Antonio Scaramuzza | Cipriana Sardu | Sara Brandolini | Tiziano Fabbri | Piero Meandri | Francesco Cannatà | T. Casetti | C. Sardu | P. Bartolo | Tiziano Fabbri | S. Brandolini | Piero Meandri
[1] L. Vignati,et al. Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment , 1997, Diabetes.
[2] M. von Mach,et al. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers. , 2003, Experimental and clinical endocrinology & diabetes.
[3] Michael Brownlee,et al. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.
[4] J. Pickup,et al. Performance assessment of the Medtronic‐MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[5] L. Vignati,et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. , 1997 .
[6] A. Lindholm,et al. Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[7] J. Selam. [How to measure glycemic instability?]. , 2000, Diabetes & metabolism.
[8] C. Homko,et al. Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects. , 2003, Diabetes care.
[9] Gernot Brunner,et al. A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes. , 2002, Diabetes care.
[10] L Heinemann,et al. Prandial Glycaemia After a Carbohydrate‐rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[11] H. Arnqvist,et al. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes. , 2001, Diabetes care.
[12] B. Zinman,et al. Insulin Lispro in CSII: Results of a Double-Blind Crossover Study , 1997, Diabetes.
[13] P. Brunetti,et al. Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function , 1995, Diabetes Care.